You are here

Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pneumococcal Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
2-5 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy children aged 2 to 5 years old identified by the Taipei City government and
are participating in Taipei City's PCV7 vaccination program.

- Informed consent obtained from parents or legal guardian.

- Eligible to receive 1 dose of PCV7

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Children with any of the following conditions: immunologic diseases; neoplastic
disorders; renal, cardiac, hepatic, or hematologic diseases; bronchodysplasia; Down
syndrome; chronic otitis media with effusion.

- Children with any acute illness including mild acute respiratory infection or fever >
38 centigrade.

NCT00488371
Pfizer
Completed
Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now